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Salivary testosterone varies with saliva-sampling adherence 
Objective: Nonadherence with scheduled saliva sampling, as encountered in ambulatory 
settings, can bias the estimation of salivary cortisol concentrations. This study is the first to 
estimate if such nonadherence is also associated with biased salivary testosterone 
concentration estimates. 
Methods: Using a standard ambulatory saliva-sampling protocol, we instructed pregnant 
women to collect saliva samples on two consecutive days at awakening, 1100h, 1500h, 
2000h, and 2200h. We estimated testosterone concentrations in the saliva samples and 
participants’ actual sampling times with an electronic medication event-monitoring system. 
We classified a saliva sample as adherent if it was sampled within a specific time window 
relative to its scheduled sampling time. We used a mixed-model analysis to distinguish 
between trait (number of adherent saliva samples per participant) and state (adherence status 
of a specific sample) adherence. 
Results: We included 60 pregnant women in this study. Seventy-five percent (448 of 600) of 
the scheduled samples indicated adherence with the sampling schedule. Participants’ trait 
adherence was associated with their diurnal profiles of salivary testosterone estimates; that is, 
adherent participants had higher salivary testosterone estimates compared with nonadherent 
participants, F(1,58) = 5.41, p = 0.023, Cohen's d = 0.67. The state adherence of a sample 
was associated with the salivary testosterone estimate of the related sample, F(1,469) = 4.48, 
p = 0.035, Cohen's d = 0.20, with delayed sampling associated with lower salivary 
testosterone estimates. 
Conclusions: The results suggest that common ambulatory nonadherence with scheduled 
saliva sampling is associated with biased salivary testosterone estimates. They will inform 
further studies estimating salivary testosterone with ambulatory saliva-sampling designs and 
highlight the relevance of strategies to improve or confirm adherence, beyond routinely used 
instructions. 
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1. Introduction 
Testosterone is a commonly used and well-established biomarker in psychoneuroendocrine 
research (Dabbs, 1993; Granger et al., 2004). Maternal testosterone concentrations during 
pregnancy have been associated with a range of pregnancy outcomes, such as offspring size at 
birth (Carlsen et al., 2006), offspring body weight (Carlsen et al., 2006; Gutnikova et al., 
2010), placental weight (Lagiou et al., 2013), and sex-specific behavior of the offspring 
(Hines, 2006). Given the large number of studies examining testosterone in pregnant women, 
and to foster scientific and clinical progress in the field, applicable and accurate testosterone 
measurement seems to be fundamental. 
Testosterone concentrations can be successfully analyzed in saliva (salivary 
testosterone, sT) based on ambulatory saliva sampling (Dabbs, 1993; Granger et al., 2004), 
for which participants are instructed to collect a series of saliva samples at scheduled 
sampling times. Particularly relevant for large-scale studies, this procedure is noninvasive, 
ecologically valid, and relatively inexpensive (Granger et al., 2004; Shiffman et al., 2008; 
Giltay et al., 2012; Kudielka et al., 2012). However, a disadvantage of ambulatory saliva 
sampling is that nonadherence with scheduled sampling times is common and often not self-
reported by participants—as observed in prior studies using covert electronic adherence-
monitoring systems (Kudielka et al., 2003; Broderick et al., 2004; Jacobs et al., 2005; Moeller 
et al., 2014). Due to the circadian decline of sT concentrations over the course of the day 
(Dabbs, 1990), nonadherence with scheduled saliva sampling may bias the estimation of sT 
concentrations and hence cause unreliable and invalid sT data. 
Such a pattern has been observed in prior studies estimating the association between 
ambulatory saliva-sampling nonadherence and salivary cortisol, another well-known and 
frequently used biomarker with a circadian rhythm (Kudielka et al., 2003; Broderick et al., 
2004; Kudielka et al., 2007; Moeller et al., 2014). However, to our knowledge, studies on the 
association between saliva-sampling nonadherence and sT estimates are lacking. Hence, when  4 
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estimating sT with ambulatory saliva-sampling designs, the need for strategies to improve or 
confirm adherence is open to question. Such strategies have been successfully used in 
ambulatory salivary cortisol research (e.g. electronic adherence-monitoring systems; see 
Adam and Kumari, 2009; Granger et al., 2012; Kudielka et al., 2012; Moeller et al., 2014) but 
are associated with additional study costs and study burden for participants. 
In sum, sT and salivary cortisol are both important and frequently assessed biomarkers 
in psychoneuroendocrine research. While several studies examined the association between 
ambulatory nonadherence with the sampling schedule and salivary cortisol estimates, there 
are, to our knowledge, no studies examining the association between such nonadherence and 
sT estimates. With a standard ambulatory saliva-sampling design and a sample of pregnant 
women, we sought to address this gap: First, we estimated whether the “trait adherence” 
(number of adherent saliva samples) of participants was associated with their diurnal profiles 
of sT estimates. Second, we estimated whether the “state adherence” of a specific saliva 
sample was associated with the sT concentration in the related sample. For this, we used 
electronic adherence-monitoring systems to assess participants’ objective adherence with 
scheduled sampling. 
 
2. Methods 
2.1. Participants 
Pregnant women were recruited at the outpatient service of the Department of Obstetrics, 
University Hospital Zurich, Switzerland, during their antenatal visits. Recruitment took place 
in the context of a previously published study (Moeller et al., 2014). We applied the following 
exclusion criteria: week of gestation <12 or >32, presence of diseases potentially affecting the 
neuroendocrine system, high-risk pregnancy, human immunodeficiency virus (HIV) infection, 
the use of hormone-containing medication, insufficient German language skills, and the 
absence of regular antenatal visits at the outpatient service. The present study was approved  5 
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by the ethics committees of Zurich and Basel and conducted in accordance with the 
Declaration of Helsinki. All participants provided written informed consent. 
 
2.2. Procedures 
Within an elaborated standard ambulatory saliva-sampling design, including 10 scheduled 
saliva samples divided over two consecutive days (awakening, and at 1100h, 1500h, 2000h, 
and 2200h), participants received standardized information for accurate saliva sampling. This 
information included restrictions (e.g. not to eat or consume caffeine 1 h before each 
scheduled saliva sampling) to minimize distortions in sT estimates. Moreover, it emphasized 
the importance of high adherence with scheduled sampling times. Participants were instructed 
to use straws and 2.0-mL safe-lock tubes (Eppendorf, Hamburg, Germany) to collect 
scheduled saliva samples. We advised them to place the tubes (Wiegand, Buelach, 
Switzerland), each prelabeled with scheduled sampling time, into small medicine containers 
directly after saliva sampling and to self-report exact sampling times with a paper-and-pencil 
diary. Participants’ objective adherence with scheduled sampling was estimated with a covert 
Medication Event Monitoring System (MEMS 6 TrackCap Monitor, Aardex Ltd., 
Switzerland), which was fitted to the medicine containers. Participants were advised to store 
the medicine container containing saliva samples in a refrigerator. After the samples were 
returned to us, we froze them at –20°C until biochemical analysis. It should be noted that 
participants were also instructed to collect saliva samples 30, 45, and 60 min after awakening 
(see Moeller et al., 2014). These samples were intended to estimate circadian awakening 
responses in biomarkers if required (e.g. cortisol awakening response, Pruessner et al., 1997). 
There is no such response for sT. Hence, these samples were not considered in this study. 
 
2.3. Measures 
2.3.1. Adherence with saliva sampling  6 
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We used objective adherence information to estimate participants’ adherence with scheduled 
sampling, measured with the MEMS 6 caps that time stamped each opening of the medical 
container. The MEMS 6 data were processed with PoverView (Aardex Ltd., Switzerland). 
The awakening samples were classified as adherent if sampled within ±10 min of the self-
reported wake-up time, and the 1100h, 1500h, 2000h, and 2200h samples as adherent if 
sampled within ±1 h of the scheduled time. These adherence criteria were adapted from prior 
research on salivary cortisol and adherence (Kudielka et al., 2003; Moeller et al., 2014). 
Delivered saliva samples with missing MEMS 6 time stamps were classified as nonadherent. 
 
2.3.2. Testosterone concentrations 
We centrifuged thawed samples at 3000 g for 10 min and analyzed sT using a commercial 
enzyme immunoassay for human saliva (Testosterone ELISA, IBL, Hamburg, Germany). 
Analytical assay sensitivity was 2 pg/ml. The intra- and interassay coefficients of variation 
were ≤ 15.1% and ≤ 6.0%, respectively.  
 
2.3.3. Demographic and other descriptive information 
Participants provided demographic and other descriptive information, including age, 
employment status, body weight, gestational age of their fetus at saliva sampling, parity, and 
number of cigarettes smoked on sampling days, via questionnaire. 
 
2.4. Statistical analysis 
We checked the data for level-one (within-subject) and level-two (between-subjects) outliers 
(Nieuwenhuis et al., 2012) and distribution properties. We used a random coefficient model, a 
type of linear mixed model (Singer and Willett, 2003), to estimate the association between 
adherence with scheduled sampling and sT concentrations. This model contained a random 
intercept and a random slope parameter when this improved model fit (based on Akaike’s  7 
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Information Criterion, AIC; Singer and Willett, 2003). Crucial for this study, this model 
allowed us to separately address trait and state adherence. 
Trait adherence relates to the overall number of adherent saliva samples of a 
participant and measuring it allowed us to estimate the association between participants’ trait 
adherence and their diurnal profiles of sT concentrations. We estimated this association by 
using the time-invariant predictor “trait adherence,” categorizing the participants into an 
adherent (>8 adherent samples of the total of 10 scheduled samples) and a nonadherent (≤8 
adherent samples) group. This 80% cutoff was chosen because studies in medical settings 
usually classify patients with adherence rates of 80% as adherent (Ho et al., 2009). We used a 
categorical predictor rather than the continuous trait adherence predictor “number of adherent 
samples” because this improved model fit in preliminary analyses. To account for linear 
trends in sT concentrations over the course of the day, we also included time of saliva 
sampling as an additional time-varying predictor. We also accounted for the sampling day, 
but this effect was negligible in all cases and is therefore not mentioned further. 
 State adherence relates to the adherence status of saliva samples and measuring it 
allowed us to estimate whether a deviation from a scheduled sampling time was associated 
with the sT concentration in the related sample. We estimated this association by entering the 
time-varying predictor “state adherence” (deviations from scheduled sampling times in 
minutes) into the model. 
We used Cohen’s d (Cohen, 1977) to estimate model-based effect sizes, based on t 
values and degrees of freedom. We also ran an adjusted model, that is, the same model 
described above but including a priori selected potential time-invariant predictors of 
testosterone as covariates: age (Granger et al., 2004), body weight (Sowers et al., 2001), 
number of cigarettes smoked on sampling days (Sowers et al., 2001; Toriola et al., 2011), 
gestational age at saliva sampling (Bammann et al., 1980), and parity (Toriola et al., 2011). 
Notably, parameter estimates based on the adjusted model were comparable to those based on  8 
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the unadjusted model. Therefore, and because some of the covariates contained missing 
values, thus increasing risk of bias and reducing statistical power, we decided to report the 
results of the unadjusted model only. Moreover, after including employment status (Purifoy 
and Koopmans, 1979) in secondary analyses as an additional covariate in the adjusted model, 
parameter estimates were still comparable (data of the adjusted models are available on 
request). 
“Deviations from scheduled sampling times in minutes” and sT data were log 
transformed to approximate normal distributions. An alpha level of 0.05 indicated statistical 
significance. We carried out the data analysis using IBM SPSS Statistics 20 for Mac OS X. 
 
3. Results 
Sixty-nine pregnant women participated in this ambulatory saliva-sampling study. We 
excluded two participants because of a MEMS 6 cap defect, two because of saliva sampling 
without using the MEMS 6 caps, and one because of prematurely delivering during the study. 
Moreover, four participants were eliminated from the statistical model because of outliers in 
their sT estimates: one because of several level-one outliers and the remaining three because 
of one level-one outlier and outliers in either the intercept or slope estimates (level-two 
coefficients). Thus, the final sample consisted of 60 pregnant women. At the beginning of the 
study, we informed 32 (53%) of these 60 participants about the electronic adherence-
monitoring system and gave timers and alarm clocks to 28 (47%) of them so they could 
remind themselves at scheduled sampling times (see also Moeller et al., 2014). Demographic 
and other descriptive information is presented in Table 1. 
-Insert Table 1 approximately here- 
 
3.1. Adherence with the saliva-sampling protocol 
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We assessed adherence and sT estimates in 10 scheduled saliva samples of 60 participants. 
Four hundred and forty-eight (75%) of the total of 600 scheduled saliva samples indicated 
adherence with the sampling schedule (see adherence criteria described in section 2.3.1.). 
Across all samples, mean deviations from scheduled sampling times were +18 min 
(standard deviation = 65.23 min), which indicates that the participants collected their saliva 
samples after rather than before the scheduled time. In Figure 1, we depicted for each sample 
the deviation from scheduled sampling time in minutes against the scheduled sampling time. 
-Insert Figure 1 approximately here- 
 
3.2. Association between trait adherence and sT estimates  
Twenty-five participants (42%) indicated trait adherence with the sampling schedule (>8 
adherent samples), and 35 (58%) indicated trait nonadherence (≤8 adherent samples). To 
estimate the association between trait adherence and sT concentrations, we compared sT 
concentrations between adherent and nonadherent participants. We found a main effect for 
trait adherence on sT concentrations, F(1,58) = 5.41, p = 0.023, Cohen's d = 0.67. As shown 
in Figure 2, adherent participants had higher diurnal sT concentrations compared with 
nonadherent participants. 
-Insert Figure 2 approximately here- 
 
3.3. Association between state adherence and sT estimates 
This analysis included 535 saliva samples. The state adherence of a saliva sample was 
significantly associated with the sT concentration in the related sample, F(1,469) = 4.48, p = 
0.035, Cohen's d = 0.20: the greater the time delay of a sample relative to its scheduled 
sampling time, the lower the sT concentration. Concentrations of sT thereby decreased per 
minute delay by a value of 0.91 on the natural logarithm scale [standard error 0.43, t(469) = 
2.12, p = 0.035].  10 
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4. Discussion 
In this study, pregnant women’s sT concentrations varied with their adherence with an 
ambulatory sampling schedule: both trait and state nonadherence were associated with a 
biased estimation of sT concentrations, leading to biased results in the case of nonadherence. 
The finding extends results from prior studies that indicated that ambulatory nonadherence 
with scheduled sampling is associated with biased salivary cortisol estimates (Kudielka et al., 
2003; Broderick et al., 2004; Kudielka et al., 2007; Moeller et al., 2014). With regard to 
cortisol, the steep variation in hormone concentration after awakening (i.e. the cortisol 
awakening response; Pruessner et al., 1997) has been considered mainly responsible for the 
bias introduced by nonadherence with the sampling schedule (Kudielka et al., 2003; Kudielka 
et al., 2012). Notably, unlike cortisol, sT shows no such steep hormone concentration 
variation (Dabbs, 1990), but still, nonadherence with scheduled sampling is associated with 
substantial bias in concentration estimates. In detail, the associations between trait and state 
adherence and sT concentration estimates indicated moderate and small effect sizes, 
respectively. 
In this study, trait adherent participants displayed higher diurnal sT profiles compared 
with trait nonadherent participants. This might be because nonadherent participants collected 
their saliva samples on average with longer delays from the sampling schedule, which is—due 
to the diurnal decline of sT concentrations—likely associated with lower diurnal sT profiles. 
Accordingly, with regard to the state adherence of a specific sample, we found that the greater 
the time delay from a scheduled sampling time, the lower the sT concentration in the related 
sample. If the associations found between ambulatory nonadherence with the sampling 
schedule and sT estimates are causal, ambulatory nonadherence with the sampling schedule 
will result in a biased estimation of sT concentrations. Alternatively, nonadherence with the 
sampling schedule may be associated with specific characteristics of participants, which in  11 
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turn may be associated with lower sT estimates. However, we could not find evidence of such 
associated characteristics when adjusting our analyses for potential confounding variables. 
Taken together, our findings indicate that nonadherence with scheduled sampling, as 
encountered in ambulatory settings, may lead on average to decreased and hence biased sT 
estimates. This may lead in turn to risk of misinterpretations, as illustrated by the following 
example: Patients with anxiety disorders may display decreased sT concentrations compared 
to healthy controls (e.g. Giltay et al., 2012). Without the option to confirm adherence, it might 
be difficult to conclude whether decreased sT estimates are directly associated with an anxiety 
disorder or rather with a bias introduced by nonadherence with the sampling schedule related 
to an anxiety disorder (cf. Kudielka et al., 2003; Moeller et al., 2014). Our findings underline 
that to reduce risk of bias when estimating sT with ambulatory saliva-sampling designs, it is 
important to specifically address the risk of nonadherence with scheduled sampling when 
designing a study. Addressing the adherence issue may be relevant not only in ambulatory 
assessment of salivary cortisol (Kudielka et al., 2003; Broderick et al., 2004; Kudielka et al., 
2007; Moeller et al., 2014) but, based on our findings, also when estimating sT in ambulatory 
settings. Notably, in our study, rates of nonadherence seemed to be severe enough to bias sT 
estimates, even though we informed participants about the importance of high adherence with 
the sampling schedule. For discussions of how adherence with scheduled ambulatory saliva 
sampling can be improved or confirmed, see Adam and Kumari (2009), Granger et al. (2012), 
and Kudielka et al. (2012). Moreover, it is important to note that factors other than 
nonadherence with scheduled sampling could also introduce biases in the estimation of sT 
concentrations: for example, not following storage temperature recommendations for saliva 
samples (Granger et al., 2004; Durdiakova et al., 2013), blood from micro-injuries in the oral 
mucosa that contaminates saliva samples (Kivlighan et al., 2004), and eating or drinking right 
before saliva sampling (Granger et al., 2012). When estimating sT within ambulatory saliva-
sampling designs, recommendations for dealing with such factors should be consistently  12 
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followed as closely as possible (for reviews see Granger et al., 2004; Al-DujailI and Sharp, 
2012; Granger et al., 2012). 
This study has some limitations: first, ambulatory sT research often applies saliva-
sampling designs with fewer scheduled samples per day than in our study (e.g. Hamilton and 
Meston, 2010), which may result in higher average adherence rates (Kudielka et al., 2003) 
than those found in our study and hence less bias in the sT estimates. However, multiple 
saliva samplings, as applied in the present study, are required to capture diurnal sT profiles 
(Al-DujailI and Sharp, 2012). Second, we specifically addressed adherence with the saliva-
sampling schedule. Obviously, trait nonadherent participants may have also adhered less 
strictly—compared to trait adherent participants—to the predefined storage protocol and 
stored their saliva samples on both study days at room temperature and not as instructed in a 
refrigerator. However, even in such a case, we would not expect substantial bias in our data, 
as Durdiakova and colleagues (2013) suggested that storing saliva samples unrefrigerated for 
few days does not introduce bias in sT estimates. Yet, we cannot absolutely rule out other 
factors related to trait nonadherence that may have partly contributed to lower diurnal sT 
profiles in trait nonadherent participants. Third, as described in the Methods section, 
participants were instructed to collect three saliva samples in the morning (30, 45, and 60 min 
after awakening; see Moeller et al., 2014) that were not considered in this study. We cannot 
rule out that adherence with the subsequent sampling schedule was impacted by the sampling 
burden of these morning samples. This should be scrutinized in future studies. Last, our 
sample consisted of pregnant women and the results may not extend to other populations. 
Despite the limitations, this study has important strengths, including an ambulatory 
saliva-sampling design covering multiple scheduled samples on two consecutive days (see Al-
DujailI and Sharp, 2012). Another strength is that we used electronic adherence monitoring 
instead of self-report questionnaires to estimate participants’ adherence with the sampling 
schedule. Prior studies showed that participants’ self-reported adherence with scheduled  13 
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sampling might be inaccurate (Kudielka et al., 2003; Broderick et al., 2004; Jacobs et al., 
2005). Furthermore, we applied a mixed-model analysis that is the method of choice for 
analyzing repeated ambulatory saliva data in which missing values are usually present (cf. 
Singer and Willett, 2003; Lane, 2008; Kudielka et al., 2012). 
In this study, sT concentrations varied with ambulatory trait and state adherence with 
the sampling schedule. Adherent participants had higher sT estimates compared with 
nonadherent participants and delayed saliva sampling was associated with lower sT 
concentration estimates. To our knowledge, this study is the first to suggest that ambulatory 
nonadherence with scheduled sampling can introduce a bias in the estimation of sT 
concentrations. Average delayed saliva sampling appears to be associated with an 
underestimation of sT concentration. Our findings will inform further studies estimating sT 
with ambulatory saliva-sampling designs. They highlight the importance of efforts to improve 
or confirm adherence with scheduled ambulatory saliva sampling.  
 14 
Salivary testosterone varies with saliva-sampling adherence 
References 
Adam, E.K., Kumari, M., 2009. Assessing salivary cortisol in large-scale, epidemiological 
research. Psychoneuroendocrinology 34, 1423-1436. 
Al-DujailI, E.A.S., Sharp, M.A., 2012. Female salivary testosterone: measurement, challenges 
and applications, In: Ostojic, S.M. (Ed.), Steroids—From Physiology to Clinical Medicine. 
InTech, Rijeka, Croatia, pp. 129-167. 
Bammann, B.L., Coulam, C.B., Jiang, N.S., 1980. Total and free testosterone during 
pregnancy. Am. J. Obstet. Gynecol. 137, 293-298. 
Broderick, J.E., Arnold, D., Kudielka, B.M., Kirschbaum, C., 2004. Salivary cortisol 
sampling compliance: comparison of patients and healthy volunteers. 
Psychoneuroendocrinology 29, 636-650. 
Carlsen, S.M., Jacobsen, G., Romundstad, P., 2006. Maternal testosterone levels during 
pregnancy are associated with offspring size at birth. Eur. J. Endocrinol. 155, 365-370. 
Cohen, J., 1977. Statistical power analysis for the behavioral sciences, Rev. ed. Academic 
Press, New York. 
Dabbs, J.M., 1990. Salivary testosterone measurements—reliability across hours, days, and 
weeks. Physiol. Behav. 48, 83-86. 
Dabbs, J.M., 1993. Salivary testosterone measurements in behavioral studies. Ann. N. Y. 
Acad. Sci. 694, 177-183. 
Durdiakova, J., Fabryova, H., Koborova, I., Ostatnikova, D., Celec, P., 2013. The effects of 
saliva collection, handling and storage on salivary testosterone measurement. Steroids 78, 
1325-1331. 
Giltay, E.J., Enter, D., Zitman, F.G., Penninx, B.W.J.H., van Pelt, J., Spinhoven, P., Roelofs, 
K., 2012. Salivary testosterone: associations with depression, anxiety disorders, and 
antidepressant use in a large cohort study. J. Psychosom. Res. 72, 205-213. 
 15 
Salivary testosterone varies with saliva-sampling adherence 
Granger, D.A., Fortunato, C.K., Beltzer, E.K., Virag, M., Bright, M.A., Out, D., 2012. Focus 
on methodology: salivary bioscience and research on adolescence: an integrated perspective. 
J. Adolesc. 35, 1081-1095. 
Granger, D.A., Shirtcliff, E.A., Booth, A., Kivlighan, K.T., Schwartz, E.B., 2004. The 
''trouble'' with salivary testosterone. Psychoneuroendocrinology 29, 1229-1240. 
Gutnikova, L.V., Aleksandrova, A.A., Shkurat, T.P., 2010. Hormone status of pregnant 
women and newborn body weight. Reprod. Biomed. Online 20, Supplement 3, 94. 
Hamilton, L.D., Meston, C.M., 2010. The effects of partner togetherness on salivary 
testosterone in women in long distance relationships. Horm. Behav. 57, 198-202. 
Hines, M., 2006. Prenatal testosterone and gender-related behaviour. Eur. J. Endocrinol. 155, 
115-121. 
Ho, P.M., Bryson, C.L., Rumsfeld, J.S., 2009. Medication adherence: its importance in 
cardiovascular outcomes. Circulation 119, 3028-3035. 
Jacobs, N., Nicolson, N.A., Derom, C., Delespaul, P., van Os, J., Myin-Germeys, I., 2005. 
Electronic monitoring of salivary cortisol sampling compliance in daily life. Life Sci. 76, 
2431-2443. 
Kivlighan, K.T., Granger, D.A., Schwartz, E.B., Nelson, V., Curran, M., Shirtcliff, E.A., 
2004. Quantifying blood leakage into the oral mucosa and its effects on the measurement of 
cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm. Behav. 46, 39-46. 
Kudielka, B.M., Broderick, J.E., Kirschbaum, C., 2003. Compliance with saliva sampling 
protocols: electronic monitoring reveals invalid cortisol daytime profiles in noncompliant 
subjects. Psychosom. Med. 65, 313-319. 
Kudielka, B.M., Gierens, A., Hellhammer, D.H., Wust, S., Schlotz, W., 2012. Salivary 
cortisol in ambulatory assessment—some dos, some don'ts, and some open questions. 
Psychosom. Med. 74, 418-431. 
 16 
Salivary testosterone varies with saliva-sampling adherence 
Kudielka, B.M., Hawkley, L.C., Adam, E.K., Cacioppo, J.T., 2007. Compliance with 
ambulatory saliva sampling in the Chicago Health, Aging, and Social Relations Study and 
associations with social support. Ann. Behav. Med. 34, 209-216. 
Lagiou, P., Hsieh, C.C., Samoli, E., Lagiou, A., Xu, B., Yu, G.P., Onoyama, S., Chie, L., 
Vatten, L.J., Adami, H.O., Trichopoulos, D., Williams, M.A., 2013. Associations of placental 
weight with maternal and cord blood hormones. Ann. Epidemiol. 23, 669-673. 
Lane, P., 2008. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF 
and MMRM approaches. Pharm. Stat. 7, 93-106. 
Moeller, J., Lieb, R., Meyer, A.H., Quack Loetscher, K., Krastel, B., Meinlschmidt, G., 2014. 
Improving ambulatory saliva-sampling compliance in pregnant women: a randomized 
controlled study. PLoS ONE 9, e86204. 
Nieuwenhuis, R., te Grotenhuis, M., Pelzer, B., 2012. influence.ME: tools for detecting 
influential data in mixed effects models. R. J. 4, 38-47. 
Pruessner, J.C., Wolf, O.T., Hellhammer, D.H., Buske-Kirschbaum, A., Auer, K.v., Jobst, S., 
Kaspers, F., Kirschbaum, C., 1997. Free cortisol levels after awakening: a reliable biological 
marker for the assessment of adrenocortical activity. Life Sci. 61, 2539-2549. 
Purifoy, F.E., Koopmans, L.H., 1979. Androstenedione, testosterone, and free testosterone 
concentration in women of various occupations. Soc. Biol. 26, 179-188. 
Shiffman, S., Stone, A.A., Hufford, M.R., 2008. Ecological momentary assessment. Annu. 
Rev. Clin. Psychol. 4, 1-32. 
Singer, J.D., Willett, J.B., 2003. Applied Longitudinal Data Analysis. Oxford University 
Press, Oxford. 
Sowers, M.F., Beebe, J.L., McConnell, D., Randolph, J., Jannausch, M., 2001. Testosterone 
concentrations in women aged 25-50 years: associations with lifestyle, body composition, and 
ovarian status. Am. J. Epidemiol. 153, 256-264. 
 17 
Salivary testosterone varies with saliva-sampling adherence 
Toriola, A.T., Vaarasmaki, M., Lehtinen, M., Zeleniuch-Jacquotte, A., Lundin, E., Rodgers, 
K.G., Lakso, H.A., Chen, T.H., Schock, H., Hallmans, G., Pukkala, E., Toniolo, P., Grankvist, 
K., Surcel, H.M., Lukanova, A., 2011. Determinants of maternal sex steroids during the first 
half of pregnancy. Obstet. Gynecol. 118, 1029-1036. 
 
 18 
Salivary testosterone varies with saliva-sampling adherence 
Figure captions 
Figure 1. Deviation from scheduled saliva sampling in minutes at the five scheduled 
sampling times. Note: Negative and positive values on the y axis indicate delayed and 
premature saliva sampling, respectively, relative to the scheduled sampling time; +0, at 
awakening. 
 
Figure 2. Salivary testosterone concentrations on a logarithmized scale stratified by trait 
adherent (>8 adherent samples of the total of 10 scheduled samples) and trait nonadherent (≤8 
adherent samples) participants. Note: Salivary testosterone concentrations were averaged 
across two collection days representing estimated values from a linear mixed model. Error 
bars denote estimates of the standard error of the group mean; +0, at awakening. 
 19 
